Challenges in collecting, accessing and evaluating post market surveillance AERS in patients receiving dietary supplements

Thromb Res. 2005;117(1-2):137-44; discussion 145-51. doi: 10.1016/j.thromres.2005.07.005. Epub 2005 Sep 1.
No abstract available

MeSH terms

  • Adverse Drug Reaction Reporting Systems*
  • Data Collection / methods*
  • Data Interpretation, Statistical*
  • Dietary Supplements / adverse effects*
  • Evidence-Based Medicine / methods*
  • Product Surveillance, Postmarketing / methods*
  • Risk Assessment / methods*
  • Risk Factors
  • United States